top of page

Ensuring sustainable industry growth 

The Environmental Risk Assessment (ERA) is a process used to evaluate the potential adverse effects of human activities (like industrial processes, waste disposal, or the release of new chemicals) on the environment.

Reality-based ERAs

In essence, a reality-based ERA value provides a more tangible, verifiable, and actionable foundation for understanding and addressing environmental risks, ensuring that interventions are both timely and effective.

Sign shark warning / danger
Risk identification

During this initial stage, potential environmental hazards or threats are recognized and catalogued. This involves understanding and listing out various environmental stressors that may cause harm to the environment or human health.

Magnifying glass on warning
Risk analysis

This stage delves deeper into understanding the nature and severity of the identified risks, often by quantifying the likelihood and magnitude of the potential impacts. Various methodologies determine exposure levels and consequences.

Warning gauge
Risk assessment

In this concluding phase, the information from the risk analysis is utilized to make determinations about the overall risk posed by the identified hazards, weighing their significance and determining the need for mitigation measures. 

Waldpfad

Directive 2001/83/EC

Directive 2001/83/EC states that ERAs are necessary for new marketing authorization applications (MAA) of medicinal products or variations thereof. The main objective of ERAs is to systematically investigate chemicals applied within drugs and medicinal use, and chemicals which are intended for respective applications. In this context, the focus of ERAs lies on the analysis of applied chemicals and chemicals intended for use and whether they can be processed as intended without causing adverse effects to human health or the environment.

Light bulb with a plant

Your benefits

The process of preparing ERAs requires interdisciplinary collaboration, rigorous data analysis, and adherence to established guidelines and regulations. It aims to provide scientifically sound and reliable information to guide informed decision-making and minimize potential ecological risks.

At IASON consulting we provide:

Interdisciplinary in-house capabilities

Unbiased opinion

Familiarity with latest regulatory requirements

Frequently asked questions

Didn't find the answer you were looking for? Connect with us using our Contact form

  • Molecule classes
    We can support you with our expertise across the full spectrum of drug development: from small to large molecules, biologics to oligonucleotides and more.
  • Development stages
    TODO
  • Species selection
    TODO
  • Technologies
    e.g. silencing novel approaches?

Request a quote

We will be happy to answer any questions you might have via e-mail or in a free online kick-off meeting. 

bottom of page